Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 6,785 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $3.97, for a total transaction of $26,936.45. Following the completion of the sale, the chief executive officer owned 132,065 shares of the company’s stock, valued at approximately $524,298.05. This trade represents a 4.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Amit Gupta also recently made the following trade(s):
- On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The shares were sold at an average price of $4.03, for a total value of $26,904.28.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.
- On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $28,526.22.
Cardlytics Trading Up 0.9%
CDLX stock opened at $4.30 on Friday. The stock’s fifty day simple moving average is $4.33 and its two-hundred day simple moving average is $6.91. Cardlytics, Inc. has a 1-year low of $3.49 and a 1-year high of $32.80. The stock has a market cap of $24.98 million, a P/E ratio of -0.23 and a beta of 0.62.
Institutional Trading of Cardlytics
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC lifted its holdings in Cardlytics by 108.3% during the 1st quarter. Renaissance Technologies LLC now owns 112,500 shares of the company’s stock worth $118,000 after purchasing an additional 58,500 shares in the last quarter. Virtu Financial LLC purchased a new position in Cardlytics during the 4th quarter valued at about $39,000. Invesco Ltd. grew its holdings in Cardlytics by 38.1% during the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after buying an additional 46,973 shares in the last quarter. Barclays PLC increased its position in shares of Cardlytics by 31,167.6% during the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after buying an additional 55,790 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in shares of Cardlytics by 15.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after buying an additional 14,273 shares during the period. 68.10% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on CDLX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a report on Thursday, June 18th. Wall Street Zen upgraded Cardlytics from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Lake Street Capital set a $10.00 price objective on Cardlytics in a report on Friday, May 8th. One equities research analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Sell” and a consensus target price of $10.00.
Read Our Latest Research Report on CDLX
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Read More
- Five stocks we like better than Cardlytics
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
